ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors

Clinical trial NCT04732065 · RECRUITING

Trial details

NCT number: NCT04732065
Sponsor: Sabine Mueller, MD, PhD
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Midline Glioma (DMG)Glioblastoma Recurrent Ependymoma Recurrent Malignant Central Nervous System Neoplasm Spinal Cord Glioma World Health Organization (WHO) Grade III Glioma CNS Tumor Central Nervous System Tumor

Start date: 2021-08-23
Primary completion: 2027-05-31
Enrollment: 208

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.